1-›.omega.-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same

A compound of the formula (I):

• ##STR15## wherein R.sup.1 and R.sup.2 are the same or different and each a hydrogen atom, a halogen atom, a hydroxy group, a C.sub.1 -C.sub.5 alkyl group, a C.sub.1 -C.sub.3 alkoxy group, a hydroxymethyl group, a formyl group, a carboxyl group, or a C.sub.1 -C.sub.3 alkoxy-carbonyl group, or when R.sup.1 and R.sup.2 bond with carbon atoms being adjacent each other, then R.sup.1 and R.sup.2 may combine to form a methylenedioxy group, an ethylenoxy group (--CH.sub.2 CH.sub.2 O--), a trimethylene group, or a tetramethylene group,
• R.sup.3 is a hydrogen atom, a halogen atom, a trifluoromethyl group, a C.sub.1 -C.sub.5 alkyl group, a C.sub.1 -C.sub.3 alkoxy group, or a phenyl group,
• R.sup.4 is a hydrogen atom, a halogen atom, a hydroxy group, a C.sub.1 -C.sub.3 alkyl group, or a (C.sub.1 -C.sub.2 alkoxy)methyl group,
• R.sup.5 is a hydrogen atom, a halogen atom, a C.sub.1 -C.sub.3 alkyl group, or a (C.sub.1 -C.sub.2 alkoxy)methyl group, or when R.sup.4 and R.sup.5 bond with a carbon atom other than the ones being next to the nitrogen atom, then R.sup.4 and R.sup.5 may combine to form an oxo group,
• p is an integer of from 2 to 6, and
• q is an integer of from 3 to 7,
• provided that when p is 2, and q is 5, then R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are not simultaneously hydrogen atoms,
• or a pharmaceutically acceptable acid addition salt thereof, or an N-oxide derivative thereof.